Sensex, Nifty turn choppy as IT, pharma stocks fall

Infosys, TCS and Sun Pharma were the biggest contributors to the losses on bourses in early trade, falling up to 2.13 per cent.

November 26, 2018 10:10 am | Updated 10:11 am IST - Mumbai:

BSE building in this file photo.

BSE building in this file photo.

The BSE benchmark Sensex pared early gains and turned choppy after opening over 200 points higher on Monday, led by fall in IT and pharma stocks amid strengthening rupee.

The 30-share Sensex pared early gains and was trading 4.38 points, or 0.01 per cent, higher at 34,985.40.

The NSE Nifty too witnessed similar movement, and was trading 10.15 points, or 0.09 per cent, higher at 10,536.75.

Infosys, TCS and Sun Pharma were the biggest contributors to the losses on bourses in early trade, falling up to 2.13 per cent.

Yes Bank, Adani Ports, ONGC, Vedanta and Kotak Bank were among other lop losers, dropping up to 5.55 per cent.

On the other hand, Bharti Airtel, Axis Bank, Asian Paints, HDFC and PowerGrid rose up to 1.77 per cent.

Investors also booked profits at higher levels after indices opened on a strong note.

Rising for the eighth straight day, the rupee climbed 39 paise to 70.30 against the US dollar in early trade Monday, as global crude prices slipped below the $60 per barrel mark and was trading at $59.47 per barrel.

On a net basis, foreign portfolio investors (FPIs) bought Rs 446 crore worth of domestic stocks on Thursday and domestic institutional investors (DIIs) were net buyers to the tune of Rs 49.68 crore, provisional data available with BSE suggested.

Elsewhere in Asia, Japan’s Nikkei rose 0.65 per cent, Taiwan’s benchmark index was up 0.83 per cent, and Shanghai Composite Index rose 0.29 per cent.

Meanwhile, the Dow Jones Industrial Average fell 178.74 points, or 0.73 percent, to 24,285.95 on Friday as the US energy sector tumbled on continued weakness in oil prices.

0 / 0
Sign in to unlock member-only benefits!
  • Access 10 free stories every month
  • Save stories to read later
  • Access to comment on every story
  • Sign-up/manage your newsletter subscriptions with a single click
  • Get notified by email for early access to discounts & offers on our products
Sign in

Comments

Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.

We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.